Improving Care

Reducing morbidity and mortality and enhancing quality of life

Informing Policy

Transforming health care at the local, national and international levels

Featured Projects

With more than 80 scientists, research at Advancing Health encompasses a wide breadth of areas


The Evidence Speaks

A recurring feature highlighting the latest in Advancing Health research

Our People

In the News

Research Resources

From design to execution, Advancing Health provides a broad range of support services

Work in Progress Seminar Series

Eugenia Oviedo-Joekes


Dr. Eugenia Oviedo-Joekes obtained her degree in Clinical Psychology at the University of Cordoba (Argentina), a PhD in Social Psychology and Behavioural Sciences Methodology in Spain, and postdoctoral studies at the Andalusian School of Public Health.

Research Interests

  • Addiction

In addition to her Advancing Health Scientist affiliation, she is a Professor at the University of British Columbia (UBC) School of Population and Public Health and a Michael Smith Foundation for Health Research Scholar. She is a Tier 1 Canada Research Chair in Person-Centered Care in Addiction and Public Health.

Her main research area is public health and addictions, with a focus on testing alternative approaches to expand and diversify treatments for vulnerable populations.

She is currently part of several Canadian Institutes of Health Research-funded grants; formerly co-investigator of North America’s first heroin-assisted treatment trial, the North American Opiate Medication Initiative (NAOMI); and formerly the principal investigator of the Study to Assess Long-Term Opioid Maintenance Effectiveness (SALOME), a randomized clinical trial that tested innovative treatments for severe, long-term opioid dependency. She is also the principal investigator of the GeMa (Gender Matters) study, which evaluates gender patterns of drug use, access to care, and health among long-term opioid users; a co-investigator of The Cedar Project, a cohort of young Aboriginal people using drugs; and the principal investigator of the Program of Outcomes Research on Treatment with Injectables for Addiction (PORTIA).